论文部分内容阅读
目的:探讨颅内静脉窦血栓形成的临床治疗方法效果。方法:对鹤岗市人民医院自2009年1月-2014年12月期间收治19例颅内静脉窦血栓形成的住院患者病因、诊断及治疗进行总结,观察其治疗效果。结果:12例患者接受了全身抗凝治疗,6例痊愈,5例好转,1例无效;7例较重患者接受了全身抗凝联合血管内介入溶栓,3例痊愈,2例好转,2例死亡(介入溶栓后出血死亡1例)。结论:低分子肝素钠抗凝治疗颅内静脉窦血栓应早期、长期使用,疗效稳定、安全可靠,针对重症颅内静脉窦血栓联合血管内溶栓治疗安全有效。
Objective: To investigate the clinical effect of intracranial venous sinus thrombosis. Methods: The etiology, diagnosis and treatment of 19 inpatients with intracranial venous sinus thrombosis admitted to Hegang People’s Hospital from January 2009 to December 2014 were summarized and their therapeutic effects were observed. RESULTS: Twelve patients received systemic anticoagulant therapy, 6 were cured, 5 were improved, and 1 was ineffective. Seven patients were treated with systemic anticoagulation and endovascular thrombolysis. Three were cured, two improved, and two improved Cases of death (bleeding after thrombolysis in 1 case). Conclusion: Low molecular weight heparin anticoagulant therapy for intracranial venous sinus thrombosis should be early and long-term use, the effect is stable, safe and reliable. It is safe and effective for the treatment of severe intracranial venous sinus thrombosis combined with intravascular thrombolysis.